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Porphyromonas gingivalis (Pg) ﬁmbriae, in addition to lipopolysaccharide, are involved in the pathogenesis of periodontal disease.
At the same time, bioactive compounds such as ﬁbronectin (FN) and melatonin in saliva and gingival crevicular ﬂuid have been
reportedtoexertapreventiveeﬀectagainstperiodontitis.Here,wereviewcurrentknowledgeregardingthepotentinhibitoryeﬀects
of FN and melatonin against Pg ﬁmbria-induced induction of proinﬂammatory cytokines, cyclooxygenase-2 (COX-2) expression,
and NF-kappa B activation in mouse macrophages and discuss their possible clinical application for prevention of periodontal
diseases induced by oral bacteria.
1.Introduction
The systemic dynamic proinﬂammatory cellular response
to localized periodontal bacteria can sometimes lead to
widespread organ damage or even death. Porphyromonas
gingivalis (Pg) is a key organism associated with peri-
odontal destruction in patients with adult periodontitis.
Many researchers (such as Kadowaki et al. [1], Bainbridge
and Darveau [2], Laine et al. [3], and Davey et al. [4])
have shown that Pg produces several virulence factors,
including outer membrane vesicles, adhesins, lipopolysac-
charide (LPS), hemolysin, and proteinases. Renshaw et al.
[5] have also shown that changes in the innate immune
response with aging include impairment of the capacity to
recognize and respond to periodontal pathogens and that
these changes may partly result from reduced expression
of cell surface receptors, such as Toll-like receptors (TLRs).
TLRs are associated with the recognition of Pg components
such as LPS and ﬁmbriae, which in turn leads to aspects
of periodontal disease such as cytokine and chemokine
p r o d u c t i o na n do r a lb o n el o s s[ 4, 6, 7]. It is well known
that the adhesion of Pg to host cells is a prerequisite step
in the pathogenesis of Pg-induced periodontal disease. Pg
binds to and invades epithelial cells, and the ﬁmbriae are
known to be intrinsically involved in the ﬁrst step of this
process. Fimbriae are peritrichous ﬁlamentous appendages,
whereas LPS is a major component of the outer membrane
of Pg and is capable of host activation, mediating the
adhesion of bacteria to both host cells and a variety of oral
substrates and molecules [8]. Pg LPS in particular is thought
to stimulate the production of both catabolic cytokines
and inﬂammatory mediators including arachidonic acid
metabolites such as prostaglandin E2. Such cytokines and
inﬂammatory mediators promote the release of tissue-
derived enzymes, the matrix metalloproteinases (MMPs),
which are destructive to extracellular matrix and bone [4,
6, 7]. Pg ﬁmbriae are also implicated in the pathogenesis
of periodontal disease [9, 10]. Davey et al. have reported
that bacterial ﬁmbriae activate a proinﬂammatory response
in the endothelium through distinct TLRs [4]. Hanazawa2 ISRN Dentistry
et al. have investigated the possible activation of mouse
peritoneal macrophages by 43-kDa Pg ﬁmbriae, including
gene expression and production of interleukin-1, as well as
bone resorption [9, 11]. Umemoto and Hamada have also
indicated that two microbial components of Pg ﬁmbriae,
the major (41-kDa) and minor (67-kDa) ﬁmbriae, may be
involvedininﬂammatoryresponses[12].Themajorﬁmbriae
induce the expression of inﬂammatory cytokines, including
TNF-alpha and IL-1beta [7], whereas the minor ﬁmbriae
induce TNF-alpha, IL-1beta, and IL-6 production in human
monocyte cell lines and murine peritoneal macrophages
[7, 13]. Hajishengallis et al. have shown that the receptors
involved in the inside-out proadhesive pathway (CD14,
TLR2, and CD11b/CD18) are important for mediating
Pg internalization within macrophages and also that Pg
appears to proactively modulate beta2 integrin adhesive
activity for intracellular uptake [14]. In addition, they
have reported interaction of Pg with complement receptor-
3 (CR3; CD11b/CD18) in monocytes/macrophages [15].
Previously, we have suggested the importance of beta2
integrin(CD11/CD18)asacellularreceptorofPgﬁmbriaeat
the initiation stage of periodontal disease pathogenesis [16].
ActivePginvasionofhumanvascularcellsandstimulationof
adhesionmoleculesinvolvedintherecruitmentofleukocytes
to sites of inﬂammation by Pg may also play a role in
the pathogenesis of systemic inﬂammatory diseases asso-
ciated with this microorganism, including atherosclerosis
[17].
Prostaglandin E2, a vasoactive eicosanoid produced by
monocytes and ﬁbroblasts, induces bone resorption and
secretion of MMP. A causal link between periodontal
inﬂammation and elevated levels of PGE2 in gingival tis-
sue and crevicular ﬂuid has been demonstrated by many
researchers [18–20].HowellandWilliams [18]ha v er e po rt ed
the importance of eicosanoids in the pathogenesis of
periodontal disease and reviewed the beneﬁcial eﬀects of
nonsteroidal anti-inﬂammatory drugs (NSAIDs) in both
animal models and humans with periodontitis [19, 20].
NSAIDs are known to act by downregulating eicosanoid
synthesis.
We have extensively investigated the Pg ﬁmbria-induced
expression of inﬂammatory cytokines and COX-2 in mouse
macrophages and the inhibitory eﬀects of the bioactive
compounds, FN and melatonin, on this expression [21, 22].
Here, we present the results of our previous experiments
and the extent of current knowledge regarding the possible
preventive eﬀects of bioactive compounds such as FN and
melatonin against periodontal disease.
2. Fibronectin
FN is a multifactor glycoprotein found in insoluble form
in blood, saliva, and other body ﬂuids [23, 24], where it
interacts with several extracellular matrix (ECM) compo-
nents such as collagen and laminin. These molecules usually
p r o v i d es t r u c t u r a ls u p p o r tt om a m m a l i a nc e l l sa n da c ta sa
scaﬀold for cell adhesion and retention of growth factors.
Several previous studies have shown that these proteins
are able to bind to various bacterial species, including
Streptococcus spp., Escherichia coli,a n dTreponema spp. [25–
28] and that ﬁmbriae play a major role in this process
[29, 30]. In general, bacterial ﬁmbriae are considered to be
a major virulence factor involved in bacterial adhesion to
and invasion of host cells. Current knowledge suggests that
the matrix proteins act as an inhibitory barrier to bacterial
adhesion. However, Pg also binds to the extracellular matrix
[31–33]. We have previously demonstrated that the ﬁmbriae
of Pg bind to FN, mediating Pg infection of host cells
[34]. Moreover, Kawata et al. have observed that ﬁmbria-
stimulated bone resorption is inhibited by pretreatment with
FN [35]. In addition, we have observed that FN is negatively
regulated by ﬁmbria-stimulated endogenous interleukin-6
and that the amount of FN in gingival crevicular ﬂuid is
decreased in patients with severe periodontal disease [36].
These observations suggest that FN might play a functional
roleasa negative regulatorof ﬁmbria-mediated pathogenesis
in the initiation and development of chronic periodontal
disease. On the other hand, the attachment of alphavbeta3-
and alpha5beta1-integrin-overexpressing CHO cells to the
polystyrene culture dishes in the presence of their ligand
ECM (vitronectin and FN) proteins, and the binding of vit-
ronectin and FN to these cells were inhibited by the ﬁmbriae
and P. gingivalis cells, respectively. These results suggest that
ﬁmbriae compete with ECM proteins for these integrins and
suppress integrin/ECM protein-related cellular functions
[37].
The results of our previous study of the binding of
FN in saliva to Pg ﬁmbriae using Western Blot assay are
shown in Figure 1. FN in saliva of a healthy subject became
bound to 43-kDa Pg ﬁmbrillin [21]. In that study, the
FN content of saliva was examined in healthy subjects
(n = 48) and patients with adult periodontal disease
(n = 55). The FN level in the saliva of the patients was
signiﬁcantly lower than that in the healthy subjects (P<
0.01). Talonpoika et al. [38] showed that both intact FN
and FN fragments were present in gingival crevicular ﬂuid
of healthy subjects and patients with periodontal disease. A
large proportion of FN was in degraded form at diseased
sites exhibiting clinical signs of inﬂammation and with
pockets at least 4mm deep, than in healthy or treated sites,
and FN was degraded into smaller peptide fragments at
diseased than at treated sites. This suggested that FN is
partially degraded in both healthy and diseased periodon-
tium and that the degree of FN degradation increases with
periodontal inﬂammation and decreases with periodontal
treatment.
TheexistenceofFNfragmentswaspreviouslyreportedto
be involved in chronic inﬂammatory diseases including peri-
odontitis and arthritis [39]. Huynh et al. reported that FN
fragments in gingival cervicular ﬂuids derived from possible
infection, inﬂammation, and wounding were 40, 68, and
120kDa in size. These fragments may be derived from the
decomposition of FN by proteases such as MMP in gingival
crevicular ﬂuid [40], and it was suggested that FN fragments
may be used as a marker of periodontal disease status.
Kapila et al. have shown that FN and speciﬁc FN fragments
can diﬀerentially induce the expression of proteinases inISRN Dentistry 3
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Figure 1: Binding of ﬁbronectin in saliva to P. gingivalis ﬁmbrillin.
Thepuriﬁedﬁmbriae(10μg/mL)weresubjectedtosodiumdodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) in 12.5%
polyacrylamidegel,andthentheseparatedsamplesweretransferred
to a PVDF membrane. The membrane was then treated for
2h at 37 ◦C with saliva from healthy subjects. Salivary FN that
became bound to the ﬁmbriae was analyzed by overlay Western
Blotting with anti-FN antibody and visualized using horseradish-
peroxidase(HRP-)conjugated goatanti-rabbitIgG.Threeindepen-
dentexperimentswereperformed,andsimilarresultswereobtained
(Copyright Wiley-Blackwell).
periodontal ligament cells, subsequently contributing to tis-
sue degradation during periodontal disease, wound healing,
and maintenance of the extracellular matrix in periodontal
tissues [41]. In addition, activities of the alternatively spliced
V region and high-aﬃnity heparin-binding domain of FN
aremediatedbytranscriptionallydependentdecreasesinp53
and c-Myc, thus inducing apoptosis in human primary cells
through the novel alternative pathway [42]. A proapoptotic
FN matrix induces ubiquitination and degradation of p53 in
the proteasome [43]. Thus, FN molecules contribute to the
novel mechanism of apoptosis associated with inﬂammatory
disease.
R e c e n t l y ,t w ot y p e so fP gﬁ m b r i a ls t r u c t u r eh a v eb e e n
described: the so-called major ﬁmbria encoded by the ﬁmA
gene and minor ﬁmbria encoded by the mfa1 gene [12,
44]. Pg ﬁmbriae recognize various host cell substances
[16, 45, 46]. The ﬁmbrillin subunit (FimA) constitutes the
main structural component, but accessory proteins such as
FimC, FimD, and FimE located downstream of FimA are
necessary for virulence against host cells [46]. Pierce et al.
have demonstrated that FimCDE components, such as CXC-
chemokine receptor 4, FN, and type 1 collagen, cooperate
and confer critical adhesive and virulence properties on Pg
ﬁmbriae [47]. Thus, binding to receptors on host cells or
extracellular matrix components such as FN may be required
in order for both major and minor ﬁmbriae to express
periodontal pathogenicity. It will be necessary to investigate
novel structural proteins of ﬁmbriae, such as FimCDE,
as potential targets for inhibitory molecular intervention
against Pg infection so that FN can function more eﬀectively
as a barrier to periodontal destruction.
3.Melatonin
Melatonin is the major secretory product of the pineal gland
and is mostly associated with regulation of the circadian
dark/lightrhythmofthehumanbody[48,49].Thismolecule
is also produced in other tissues such as the retina, bone
marrow, gastrointestinal tract, gonads, and immune system
[50–52]. Melatonin has been recently recognized as a potent
antioxidant and immunomodulator and is considered to be
an important natural oncostatic agent [48, 49]. Melatonin
passes into saliva by passive diﬀusion from the bloodstream.
Cutando et al. [53, 54]a n dG ´ omez-Moreno et al. [55, 56]
have focused on melatonin and its preventive eﬀects against
oral cavity disorders and also in oxidative stress-related oral
diseases and periodontal inﬂammation.
COX-2isthekeyenzymethatcatalyzesthetwosequential
steps in the biosynthesis of prostaglandins (PG)s from
arachidonic acid. COX-2, the inducible isoform of COX,
plays a critical role in the inﬂammatory response, and its
overexpression has been associated with several pathologies
including neurodegenerative diseases and various types of
cancer. Mayo et al. have investigated the suppressive eﬀect of
melatonin and its metabolites on the activities of COX-2 and
inducible nitric oxide synthase (iNOS), using LPS-activated
RAW264.7 macrophages as a model [57]. In addition, Deng
et al. have shown that melatonin, but not tryptophan or
serotonin, time- and concentration-dependently inhibits the
LPS-induced protein levels and promoter activities of COX-
2 and iNOS in RAW264.7 cells [58]. Note that melatonin,
like serotonin and tryptophan, is an indole derivative.
Furthermore, Noguchi et al. have suggested that COX-
2-dependent exogenous PGE2 downregulates IL-1alpha-
induced production of matrix metalloproteinase-13 (MMP-
13)viaE-typeprostaglandin(EP)receptor1(EP1)inhuman
periodontal ligament cells [59]. It is considered that endoge-
nous PGE2 may be involved in regulating the destruction
of extracellular matrix components in periodontal lesions.
However, exogenous PGE2 may act as an anti-inﬂammatory
eﬀect via the inhibitory prostanoid receptor(s) EP receptor
[60]. Therefore, melatonin may prevent various oral diseases
including periodontitis, even neoplastic diseases such as pre-
cancerous leukoplakia, lichen planus, and oral cancer [56].
Therefore, to investigate whether COX-2 expression and
n u c l e a rf a c t o rk a p p aB( N F - κB) activation in RAW264.7 cells
stimulated by Pg ﬁmbriae can be suppressed by melatonin,
it is useful to consider the contribution of melatonin to not
onlythepreventionoforaldiseases,butalsotheregeneration
of alveolar bone through stimulation of type I collagen ﬁber
production and modulation of osteoblastic and osteoclastic
activity mediated by cellular proteins. Fimbria-dependent
activation of cell adhesion molecule expression in Pg-
infected endothelial cells may play a role in the pathogenesis
of systemic inﬂammatory diseases such as atherosclerosis, as
well as periodontal diseases associated with this microorgan-
ism[61].Thus,chronicinfectioninducedbyPgthatislinked
to the initiation of periodontitis and atherosclerosis may be
prevented by melatonin. Here, we present the results of our
recent experimental study of COX-2 expression and NF-
κB activation in RAW264.7 cells stimulated by Pg ﬁmbriae4 ISRN Dentistry
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Figure 2: The chemical structures of melatonin and indole (Copyright In Vivo, Athens, Greece).
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Figure 3: Inhibition of ﬁmbria-stimulated NF-κB activation by melatonin and indole in RAW264.7 cells. Left hand panel: inhibitory eﬀects
of melatonin and indole on ﬁmbria-stimulated NF-κB binding. The cells were pretreated for 30min with or without the indicated doses of
melatonin or indole and then incubated with or without ﬁmbriae at 4μg/mL for 1h. A gel mobility shift assay was performed with nuclear
proteins and 32P-labeled oligonucleotide containing the NF-κB consensus sequence. Three independent experiments were performed, and
similar results were obtained. Right hand panel: inhibitory eﬀects of melatonin and indole on phosphorylation-dependent proteolysis of
ﬁmbria-stimulated IκB-α. The cells were pretreated for 30min with or without melatonin or indole at 10μM and then incubated with or
without ﬁmbriae at 4μg/mL. Equal amounts of cell lysates were analyzed by Western Blotting after SDS-PAGE with phosphospeciﬁc anti-
IκB-α antibody, anti-IκB-α antibody, or anti-β-actin antibody. Three independent experiments were performed, and similar results were
obtained (Copyright In Vivo, Athens, Greece).
in the absence or presence of melatonin and indole [22],
the latter being used as a negative control. The structures
of melatonin and indole are shown in Figure 2. Melatonin
at noncytotoxic concentrations was shown to signiﬁcantly
inhibit ﬁmbria-induced COX-2 expression in RAW264.7
cells at both the mRNA and protein levels using Northern
andWesternBlotting,respectively.Incontrast,theinhibitory
eﬀect of indole was not complete within a concentration
range of 10–100μM. Furthermore, Western Blotting showed
that melatonin strongly inhibited the production of COX-2,
whereas indole at 100μM had only a weak inhibitory eﬀect.
These ﬁndings suggested that in RAW264.7 cells, melatonin
exerted a markedly stronger inhibitory eﬀect on COX-2
expression than indole [22].
To clarify whether melatonin and indole are inhibitors
of ﬁmbria-stimulated NF-κB, their inhibitory eﬀects on the
binding of NF-κB to its consensus sequence in ﬁmbria-
stimulated RAW264.7 cells were investigated using EMSA.
The ﬁmbria-stimulated binding of NF-κBw a sm a r k e d l y
inhibited by melatonin, whereas indole inhibited the bind-
ing only weakly (Figure 3). In addition, melatonin clearly
inhibited both the phosphorylation and degradation of IκB-
α stimulated by the ﬁmbriae. These ﬁndings suggest that
melatonin is a potent inhibitor of ﬁmbria-triggered cellular
signaling in RAW264.7 cells.
Deng et al. previously reported that melatonin, but not
tryptophan or serotonin, inhibited LPS or LPS plus IFNγ-
induced COX-2 and iNOS transcriptional activation inISRN Dentistry 5
RAW264.7 cells by suppressing p52 acetylation [58]. The
most well-known derivative of indole is the amino acid
tryptophan,theprecursoroftheneurotransmitterserotonin.
Melatonin, serotonin, and tryptophan share a common
tryptophan backbone. Among them, however, melatonin
alone exhibited anti-inﬂammatory activity, suggesting the
requirementofamelatoninsidechainforinhibitionofCOX-
2 and iNOS expression at both the protein and gene levels.
The basic structure of melatonin comprises an indole ring
with a methoxy group at position 5 (5-methoxy group) and
an acylaminoethyl side-chain at position 3, whereas indole
has no side chains (Figure 2). The two side chains on the ring
maybeimportantforinhibitingCOX-2andiNOSexpression
at the protein and gene levels.
Our ﬁndings suggest that melatonin signiﬁcantly inhibits
Pg ﬁmbria-induced expression of the COX-2 gene through
suppression of NF-κB activation in RAW264.7 cells and
thus may help prevent Pg-induced oral diseases and chronic
infections in the body.
Korkmazetal.haveshownthatmelatonineﬃcientlypro-
tects biomolecules such as lipids, proteins, and nucleic acid
from nitrooxidative stress [62], and Garc´ ıa et al. have
reported that melatonin prevents changes in microsomal
membrane ﬂuidity during lipid peroxidation, suggesting a
cytoprotective eﬀect [63]. We investigated the cytotoxicity
of melatonin towards RAW264.7 cells and found that it was
much lower than that of indole, possibly due to the lower
hydrophobicity of the former [22]. Tan et al. have reported
that the protective eﬀect of melatonin on biomolecules
may be related to its ability to scavenge reactive oxygen
species(ROS)andreactivenitrogenspecies(RNS)[64].Also,
Antol´ ın et al. have shown that melatonin exerts a cytoprotec-
tive eﬀect by inhibiting aminolevulinate synthase (and thus
porphyrin synthesis) and some prooxidant enzymes [65].
Furthermore, the radical-scavenging activity of melatonin
t o w a r d sa l k y la n dp e r o x yr a d i c a l si sr e p o r t e d l yg r e a t e rt h a n
that of indole [66]. Melatonin scavenges a variety of ROS
and RNS, including the hydroxyl radical, hydrogen peroxide,
singlet oxygen, nitric oxide, and the peroxynitrite anion [48].
Thecytoprotectiveactivityofmelatoninmaybederivedfrom
its high endogenous radical-scavenging activity, which in
turn could explain its anti-inﬂammatory activity.
Recently, NSAID-like compounds have become a focus
of attention with regard to the prevention of various
chronic diseases, including oral diseases such as peri-
odontitis and precancerous diseases such as lichen planus
[19, 20, 67]. We previously investigated the antioxidative
and anti-inﬂammatory activity of some natural and syn-
thetic phenols, which are NSAID-like compounds possess-
ing high antioxidative activity. We found that, in partic-
ular, ortho-dimer phenols, bis-BHA (3,3 -di-t-butyl-5,5 -
dimethoxy-1,1 -biphenyl-2,2 diol), showed good radical-
scavenging activity and also inhibited Pg ﬁmbria-stimulated
inﬂammatory cytokine expression and NF-κBa c t i v a t i o ni n
RAW264.7 cells [68]. In addition, we have conﬁrmed that
magnolol and/or honokiol, which are hydroxylated biphenyl
compounds isolated from Magnolia oﬃcinalis, inhibit the
ﬁmbria-stimulated COX-2 expression resulting from NF-κB
activation in the same cells (data not shown). These ﬁndings
suggestthattheanti-inﬂammatoryactivityofmelatoninmay
be related to its potent radical-scavenging activity.
4. Conclusions
The inhibitory eﬀect of FN on Pg ﬁmbria-induced proin-
ﬂammatory cytokines and that of melatonin on Pg ﬁmbria-
induced COX-2 and NF-κB expression indicate that these
bioactivecompoundspossessanti-inﬂammatoryactivityand
may be applicable clinically for the prevention of oral
diseases and chronic infections in the body induced by
periodontopathic bacteria.
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